课题基金 / 基金详情

Adjuvant Development in the context of a vaccine to protect against tuberculosis

Adjuvant Development in the context of a vaccine to protect against tuberculosis
预防结核病疫苗的佐剂开发
批准号:
10453430
负责人:
NIKOLAI PETROVSKY
金额:
$117.05万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2018
资助国家:
美国
项目状态:
已结题
起止时间:
2018-09-30 至 2023-09-29

项目摘要

项目成果

NIKOLAI PETROVSKY的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
This contract supports the development of an adjuvant through immunological characterization studies and compound optimization, up to and including IND-enabling studies. The main emphasis will be on testing and further development of the adjuvant for human licensure as a component of a licensed or investigational vaccine to protect against one or more non-HIV disease pathogens relevant to human disease.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Adjuvant Development in the context of a vaccine to protect against tuberculosis
  • 批准号:
    10650130
  • 项目类别:
  • 资助金额:
    $155.2万
  • 财政年份:
    2018
  • 负责人:
    NIKOLAI PETROVSKY
  • 依托单位:
Adjuvant Development in the context of a vaccine to protect against tuberculosis
  • 批准号:
    10229328
  • 项目类别:
  • 资助金额:
    $147.32万
  • 财政年份:
    2018
  • 负责人:
    NIKOLAI PETROVSKY
  • 依托单位:
High-throughput screening for novel adjuvant discovery for vaccines against influenza virus
  • 批准号:
    9345559
  • 项目类别:
  • 资助金额:
    $40.0万
  • 财政年份:
    2014
  • 负责人:
    NIKOLAI PETROVSKY
  • 依托单位:
Vaccine development for SARS-CoV2
  • 批准号:
    10260033
  • 项目类别:
  • 资助金额:
    $50.0万
  • 财政年份:
    2014
  • 负责人:
    NIKOLAI PETROVSKY
  • 依托单位:
国内基金
海外基金
Agonist-GPR119-Gs复合物的结构生物学研究
  • 批准号:
    32000851
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    24.0万元
  • 批准年份:
    2020
  • 负责人:
    乔安娜
  • 依托单位: